Pharma could propel Africa into the forefront of healthcare

Paul-MillerThe Fourth Industrial Revolution has a profound effect on the pharma industry. New technology assists with earlier diagnoses, enhanced manufacturing capabilities and improved treatment plans by using data to better understand patients’ needs. This is according to Cipla South Africa’s CEO, Paul Miller, who spoke at the 10th BRICS summit, which took place from 25 to 27 July at the Sandton Convention Centre.

Sanofi bets big on India

Global-dataSanofi Genzyme, the specialty care global business unit of French multinational pharma company Sanofi, has recently launched its multiple sclerosis (MS) drug Aubagio (teriflunomide, 14 mg) in India. However, the company needs to be wary of the fierce generic competition and cost sensitivity of the Indian market, cautions leading data and analytics company GlobalData.

The Adcock Ingram Group reports positive trading performance

Pills-pixabayThe Adcock Ingram Group is pleased to report a 20 percent increase in trading profit for the year ended 30 June 2018, particularly when considering the price-regulated environment in which it operates and the difficult economic conditions in South Africa.

Werum IT Solutions honoured as Top Pharma and Life Science Solution Provider 2018 in Asia-Pacific

Werum-certificateWerum IT Solutions was recognised as one of the “Top 10 Pharma & Life Science Solution Providers 2018” by APAC CIO Outlook. With the certificate of honour, a distinguished panel of CIOs, CEOs and VCs including the APAC CIO Outlook editorial board selected companies that are successfully tackling the challenges of the pharma and biotech industries by adopting technology advancements and paving the way to Pharma 4.0. Werum IT Solutions is the only MES supplier which has received this prestigious award this year.

Cipla grows national footprint with Mirren acquisition

Cipla-acquisitionCipla Medpro South Africa (Cipla Medpro), wholly owned subsidiary of Cipla Limited, India (Cipla), has announced plans to acquire a 100 percent stake in Mirren. Mirren is a local manufacturer and distributor of over-the-counter (OTC) pharma products and has been in operation for 35 years.

Would you like to receive our FREE e-newsletter?

* indicates required